ArticleVaccines2025
Anti-SARS-CoV-2 B and T-Cell Immune Responses Persist 12 Months After mRNA Vaccination with BNT162b2 in Systemic Lupus Erythematosus Patients Independently of Immunosuppressive Therapies.
Mario Ferraioli, Alessandra Aiello, Immacolata Prevete, Maria Sole Chimenti, Luigi De Marco, Silvia Meschi, Davide Mariotti, Valentina Vanini, Gilda Cuzzi, Andrea Salmi and 6 more
Abstract read
In one paragraphArticle in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
16 authors.
Mario FerraioliRheumatology, Immunology and Clinical Allergology Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.ORCID 0009-0007-1074-0861 Alessandra AielloTranslational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy.ORCID 0000-0003-2681-9383 Immacolata PreveteU.O.C. Reumatologia, Azienda Ospedaliera San Camillo-Forlanini, 00152 Rome, Italy.
Maria Sole ChimentiRheumatology, Immunology and Clinical Allergology Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.ORCID 0000-0002-1343-1729 Luigi De MarcoRheumatology, Immunology and Clinical Allergology Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
Silvia MeschiLaboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy.ORCID 0000-0003-0924-993X Davide MariottiLaboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy.ORCID 0000-0002-7698-1103 Valentina VaniniTranslational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy.
Gilda CuzziTranslational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy.
Andrea SalmiTranslational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy.
Stefania NotariCellular Immunology and Pharmacology Laboratory, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy.ORCID 0000-0002-7692-6606 Valeria MelliniTranslational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy.
Vincenzo PuroU.O.C. Risk Management, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy.
Fabrizio MaggiLaboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy.ORCID 0000-0001-7489-5271 Delia GolettiTranslational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy.ORCID 0000-0001-8360-4376 Gian Domenico SebastianiU.O.C. Reumatologia, Azienda Ospedaliera San Camillo-Forlanini, 00152 Rome, Italy.ORCID 0000-0003-2969-6649 Funding
Camera di Commercio, Industria e Artigianato di Roma DG 395/2021European Project SHARP 848096GRUPPO LES ITALIANO ODV DonationMinistero della Salute Ricerca Corrente (Linea 1)Valentino SpA DG 254/2021
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
COVID-19immune responsemRNA vaccineSLEtherapyvaccination
Identifiers
PMID40333295
PMCPMC12031101
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390